Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;32(10):1224-1228.
doi: 10.1080/09540121.2019.1687835. Epub 2019 Nov 7.

Acceptability of electronic nicotine delivery systems (ENDS) among HIV positive smokers

Affiliations

Acceptability of electronic nicotine delivery systems (ENDS) among HIV positive smokers

Jessica Yingst et al. AIDS Care. 2020 Oct.

Abstract

Electronic nicotine delivery systems (ENDS) have the potential to help smokers living with HIV/AIDS (PLWHA) to reduce harms from tobacco use. However, little is known about ENDS use among PLWHA. This study's aim was to evaluate the acceptability of two types of ENDS among PLWHA not planning to quit smoking. The study utilized a cross-over design where participants used two ENDS in a random order as smoking substitutes during two use periods separated by 7 days. Exhaled carbon monoxide (CO) was analyzed and participants reported daily cigarette and ENDS use and completed ratings on ENDS acceptability. Participants (n = 17) were a mean age of 49.1 years (SD = 8.8), were 53% white, and 59% male. All participants had controlled HIV disease status. Participants smoked a mean of 16.9 (SD = 7.9) CPD at baseline. Overall, CPD significantly decreased during both ENDS use periods (p < .01) but there were no differences in reduction between the different devices. CO decreased from baseline to follow-up only during the button-activated ENDS use period (p = .03), but there were no differences between ENDS devices. There were no significant differences in ratings of acceptability between ENDS devices. These results suggest that ENDS could be a harm reduction tool for smokers with HIV.

Keywords: Electronic cigarettes; HIV; tobacco use.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests

JF has done paid consulting for pharmaceutical companies involved in producing smoking cessation medications, including GSK, Pfizer, Novartis, J&J, and Cypress Bioscience. TE is a paid consultant in litigation against the tobacco industry and is named on a patent application for a device that measures the puffing behavior of electronic cigarette users. There are no other competing interests to report for other authors.

Figures

Figure 1:
Figure 1:
Study Flow Chart
Figure 2:
Figure 2:
Change in Cigarette smoking from baseline to follow-up for each ENDS use period

References

    1. Baweja R, Curci K, Yingst J, Veldheer S, Wilson S, Nichols T,… Foulds J. (2016). Views of Experienced Electronic Cigarette Users. Addition Research and Theory, 21(1), 80–88. doi:10.3109/16066359.2015.1077947 - DOI - PMC - PubMed
    1. Breland A, Soule E, Lopez A, Ramôa C, El‐Hellani A, & Eissenberg T (2017). Electronic cigarettes: what are they and what do they do? Annals of the New York Academy of Sciences, 1394(1), 5–30. doi:doi:10.1111/nyas.12977 - DOI - PMC - PubMed
    1. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, & Rapkin BD (2005). Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res, 7(4), 511–522. doi:10.1080/14622200500186064 - DOI - PubMed
    1. Calvo-Sanchez M, & Martinez E (2014). How to address smoking cessation in HIV patients. HIV Med. doi:10.1111/hiv.12193 - DOI - PubMed
    1. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, & Polosa R (2013). EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLOS ONE, 8(6), e66317. doi:10.1371/journal.pone.0066317 - DOI - PMC - PubMed

Publication types